Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: ACADIA Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Edgewise Therapeutics Inc. June 4, 202695.8%
-
ACADIA Pharmaceuticals Inc. May 29, 202589.0%
-
Mirum Pharmaceuticals Inc. May 29, 202549.7%
-
Pacira BioSciences Inc. June 11, 202449.9%
-
Edgewise Therapeutics Inc. June 9, 202380.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Pacira BioSciences Inc. | Grant or award | +6,405 | — | — |
| May 29, 2026 | ACADIA Pharmaceuticals Inc. | Option exercise | +8,107 | — | — |
| Sep 11, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +17,000 | $15.00 | $255,000 |
| Sep 11, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −15,509 | $74.34 | $1,152,939 |
| Sep 11, 2025 | Mirum Pharmaceuticals Inc. | Open-market sale | −1,491 | $75.07 | $111,929 |
| Jun 11, 2025 | Pacira BioSciences Inc. | Grant or award | +6,163 | — | — |
| Jun 4, 2025 | ACADIA Pharmaceuticals Inc. | Open-market sale | −14,446 | $21.78 | $314,634 |
| May 29, 2025 | Mirum Pharmaceuticals Inc. | Option exercise | +5,703 | — | — |
| May 29, 2025 | ACADIA Pharmaceuticals Inc. | Option exercise | +9,387 | — | — |
| Aug 16, 2024 | Pacira BioSciences Inc. | Open-market purchase | +1,000 | $12.81 | $12,810 |
| Jun 12, 2024 | Pacira BioSciences Inc. | Grant or award | +5,230 | — | — |
| May 29, 2024 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,652 | — | — |
| Jun 14, 2023 | Pacira BioSciences Inc. | Grant or award | +1,775 | — | — |
| Jun 12, 2023 | ACADIA Pharmaceuticals Inc. | Open-market sale | −4,500 | $24.87 | $111,915 |
| Jun 5, 2023 | Pacira BioSciences Inc. | Open-market sale | −600 | $38.74 | $23,244 |
Questions about Laura Brege
What boards is Laura Brege on?
Laura Brege sits on the boards of ACADIA Pharmaceuticals Inc., Edgewise Therapeutics Inc., Mirum Pharmaceuticals Inc. and Pacira BioSciences Inc.
How long has Laura Brege served on boards?
Our records show at least 14 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.